SeaStar Medical (ICU) vs Intelligent Bio Solutions (INBS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
SeaStar Medical is the larger company by market cap ($5.0 million vs $4.6 million), about 1.1 times the size. Intelligent Bio Solutions converts more of its revenue into profit, with a net margin of -294.9% versus -984.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ICU | INBS |
|---|---|---|
| Share price | $0.935 | $1.39 |
| Market cap | $4.97M | $4.61M |
| 1-day change | -10.95% | -7.95% |
| YTD return | -61.04% | — |
| 1-year return | -69.34% | — |
| 5-year return | -99.96% | — |
| Forward P/E | — | 3.97 |
| EPS (TTM) | $-2.71 | $-6.38 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.23M | $4.22M |
| Revenue growth (YoY) | +814.07% | +38.09% |
| Net income (latest FY) | $-12.15M | $-12.43M |
| Gross margin | 95.71% | 48.63% |
| Operating margin | -986.63% | -299.11% |
| Net margin | -984.60% | -294.91% |
| 52-week high | $5.38 | $24.90 |
| 52-week low | $0.761 | $1.35 |
| Distance from 52-week high | -82.62% | -94.42% |
| Analyst consensus | none | none |
| Avg. price target upside | +969.52% | +763.31% |
| Average volume | 196.27K | 129.01K |
| Shares outstanding | 5.32M | 3.32M |
| Employees | 18 | 59 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Intelligent Bio Solutions is more profitable, keeping -294.9 cents of every revenue dollar as net income versus -984.6 cents for SeaStar Medical.
- SeaStar Medical grew revenue faster in its latest fiscal year (+814.07% vs +38.09%).
About SeaStar Medical
ICU stock →SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis.
Health Care · Medical/Dental Instruments · 18 employees
About Intelligent Bio Solutions
INBS stock →Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform.
Health Care · Medical/Dental Instruments · 59 employees
ICU vs INBS FAQ
Which is bigger, SeaStar Medical or Intelligent Bio Solutions?
SeaStar Medical (ICU) is larger, with a market capitalization of $4.97M compared with $4.61M for Intelligent Bio Solutions (INBS).
Are SeaStar Medical and Intelligent Bio Solutions in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.